STOCK TITAN

Hempacco Co (HPCO) Financials

HPCO OTC
FY2023 annual
Revenue $4.0M +2.0% YoY
Net Income -$13.4M n/m YoY
Free Cash Flow -$6.0M n/m YoY
Operating Cash Flow -$5.8M n/m YoY
Market Cap $592 as of Nov 10, 2026
Price / Sales 0.0x on $4.0M revenue, FY2023
Price / Earnings n/m net loss, so no earnings multiple, FY2023
Price / Book n/m negative shareholder equity, so no book multiple, Q4 FY2023

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings Latest period FY2023, ended Dec 31, 2023 Reported Currency USD FYE December

Newest figures come from the filing for FY2023, filed Aug 9, 2024. Each column of the statement tables below links to the filing it was taken from.

Hempacco Co Inc (HPCO) reported $4.0M in revenue for fiscal year 2023, up 2.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.

Rhea AI HPCO FY2023

Nearly flat sales masked a cost structure that turned a modest gross profit into a gross loss and negative equity.

From FY2022 to FY2023, revenue increased only 2.0% while cost of revenue rose 35.6%; the resulting gross-margin deterioration of 36.1 percentage points indicates weakness began before overhead, not merely in corporate spending. SG&A then rose 98.4%, showing that both production economics and operating expenses moved against the business at the same time.

The balance-sheet posture became structurally strained: FY2023 liabilities reached $18.82M against $18.04M of assets, leaving negative equity. Current liabilities of $12.89M versus current assets of $3.28M points to substantial short-term funding pressure, while the year also included $9.02M of financing inflows.

The cash shortfall was operational: operating cash flow was -$5.84M and free cash flow was -$6.02M. Because capital expenditures were only $179K, the near-match between those cash measures indicates reinvestment was not the main drain; reported liquidity equaled just 0.2 months of the latest annual operating outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Hempacco Co Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Altman Z-Score Distress
-4.67

Hempacco Co Inc scores -4.67, below the 1.81 distress threshold. The score is pulled down most by an operating loss of $13.2M against total assets of $18.0M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Hempacco Co Inc passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing
N/A

Hempacco Co Inc reported a net loss of $13.4M while operations used $5.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk
N/A

Hempacco Co Inc reported an operating loss of $13.2M against $270K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$2.0M
YoY+285.8%
QoQ+53.9%

Hempacco Co Inc generated $2.0M in revenue in Q4 2023. This represents an increase of 285.8% from the same quarter a year earlier. Against the prior quarter it is up 53.9%.

EBITDA
-$6.8M
QoQn/m

Hempacco Co Inc's EBITDA was -$6.8M in Q4 2023, measuring earnings before interest, taxes, depreciation, and amortization. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$7.2M
YoYn/m
QoQn/m

Hempacco Co Inc reported a net loss of $7.2M in Q4 2023. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q4 2023.

Cash & Balance Sheet

Free Cash Flow
-$889K
QoQn/m

Hempacco Co Inc recorded an outflow of $889K in free cash flow in Q4 2023, representing a cash shortfall after capex. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Debt
$110K
YoY-80.0%
QoQ+543.2%

Hempacco Co Inc held $110K in cash against $0 in long-term debt as of Q4 2023, with $12.9M of liabilities due within a year.

Dividends Per Share

Not reported for Q4 2023.

Shares Outstanding

Not reported for Q4 2023.

Margins & Returns

Gross Margin
-24.6%
YoY+51.7pp
QoQ+8.4pp

Hempacco Co Inc's gross margin was -24.6% in Q4 2023, indicating the percentage of revenue retained after direct costs. This is up 51.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 8.4 percentage points.

Operating Margin

Not shown for Q4 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q4 2023: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for Q4 2023.

Capital Allocation

Capital Expenditures
$16K
QoQ+8.1%

Hempacco Co Inc invested $16K in capex in Q4 2023, funding long-term assets and infrastructure. Against the prior quarter it is up 8.1%.

R&D Spending

Not reported for Q4 2023.

Share Buybacks

Not reported for Q4 2023.

HPCO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HPCO quarterly income statement
MetricQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22FilingQ1'22Filing
Revenue$2.0M+285.8%$1.3M+123.9%$255K-86.4%$424K-56.3%$529K$592K+39.3%$1.9M$971K
Cost of Revenue$2.4M+157.8%$1.8M+194.7%$432K-69.1%$460K-42.4%$929K$599K+89.9%$1.4M$799K
Gross Profit-$503Kn/m-$438Kn/m-$177K-137.2%-$97K-156.6%-$404K-$6K-105.8%$477K$172K
R&D ExpensesN/AN/AN/AN/A$0$0n/mN/AN/A
SG&A Expenses$3.5M+232.1%$1.3M+35.4%$1.2M+124.8%$917K-1.1%$1.1M$993K+610.4%$524K$927K
Operating Income-$7.1Mn/m-$2.1Mn/m-$1.6Mn/m-$2.4Mn/m-$5.1M-$1.0Mn/m-$92K-$860K
EBITDA-$6.8M-$2.1Mn/m-$1.6Mn/m-$2.3Mn/mN/A-$1.0M-$69K-$838K
Interest ExpenseN/AN/AN/AN/AN/A$4K+4.9%N/AN/A
Income TaxN/AN/AN/AN/A$0$0n/mN/AN/A
Net Income-$7.2Mn/m-$2.3Mn/m-$1.6Mn/m-$2.4Mn/m-$5.1M-$1.0Mn/m-$97K-$877K

Not reported in any period shown, so not listed: EPS (Basic), EPS (Diluted), Diluted Shares (Avg).

HPCO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HPCO quarterly balance sheet
MetricQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22FilingQ1'22Filing
Total Assets$18.0M+90.3%$14.4M-1.5%$12.6M$13.8M$9.5M+25.3%$14.7MN/AN/A
Current Assets$3.3M+71.9%$3.2M-38.9%$4.4M$6.0M$1.9M-9.9%$5.2MN/AN/A
Cash & Equivalents$110K-80.0%$17K-99.4%$1.4M+1947.9%$4.0M+57172.0%$548K-41.3%$3.0M+6529.7%$68K$7K
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0$0
Inventory$2.5M+294.1%$910K+13.9%$1.2M$813K$645K+224.3%$799KN/AN/A
Accounts Receivable$226K-2.2%$554K+82.5%$230K$396K$231K+60.3%$304KN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0$0
Goodwill$2.6Mn/mN/AN/AN/A$0N/AN/AN/A
Total Liabilities$18.8M+879.3%$5.7M+171.4%$2.0M$1.7M$1.9M-59.1%$2.1MN/AN/A
Current Liabilities$12.9M+747.9%$5.5M+234.7%$1.8M$1.4M$1.5M-63.5%$1.6MN/AN/A
Non-Current Liabilities$5.9M+1377.0%$171K-61.6%$0$230K$402K-24.9%$445KN/AN/A
Long-Term Debt$0-100.0%$0-100.0%$0$0$143K-15.2%$158KN/AN/A
Total Equity-$368K-104.8%$9.0M-28.9%$10.7M$12.3M$7.7M+165.6%$12.6MN/AN/A
Retained Earnings-$23.6Mn/m-$16.6Mn/m-$14.4M-$12.8M-$10.5Mn/m-$5.5MN/AN/A

HPCO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HPCO quarterly cash flow statement
MetricQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22FilingQ1'22Filing
Operating Cash Flow-$873Kn/m-$1.2Mn/m-$1.9M-15651.2%-$2.0Mn/m-$1.2M-590.0%-$2.1M$12K-$1.1M
Depreciation & Amortization$282K$53K+40.8%$33K+45.5%$31K+36.8%N/A$38K$23K$22K
Stock-Based CompensationN/AN/AN/A$13Kn/mN/AN/AN/A$0
Capital Expenditures$16K$15K-90.8%$112K+3634.5%$36K+802.0%N/A$162K$3K$4K
Free Cash Flow-$889K-$1.2Mn/m-$2.0M-22081.2%-$2.0Mn/mN/A-$2.3M$9K-$1.1M
Investing Cash Flow-$3.4M-1681.0%-$15Kn/m-$112Kn/m-$36K-200.6%$218Kn/m-$315K-$3K$36K
Financing Cash Flow$4.4Mn/m-$204K-103.8%-$673K-1403.6%$5.5M+3085.5%-$1.5M-308.2%$5.3M$52K$172K

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

HPCO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

HPCO quarterly financial ratios
MetricQ4'23FilingQ3'23FilingQ2'23FilingQ1'23FilingQ4'22FilingQ3'22FilingQ2'22FilingQ1'22Filing
Gross Margin-24.6%+51.7pp-33.0%-31.9pp-69.7%-95.1pp-22.9%-40.7pp-76.3%-1.1%-26.9pp25.4%17.7%
Operating Margin-348.9%-159.4%-640.7%-560.2%-962.1%-176.3%-4.9%-88.6%
Net Margin-352.4%-170.6%-632.9%-560.5%-966.4%-177.2%-5.2%-90.3%
Return on EquityN/A-25.3%-16.9pp-15.0%-19.4%-66.8%-8.3%N/AN/A
Return on Assets-39.9%+14.1pp-15.7%-8.5pp-12.8%-17.2%-53.9%-7.2%N/AN/A
Current Ratio0.25-1.0x0.58-2.6x2.464.191.25+0.7x3.17N/AN/A
Debt-to-EquityN/A0.000.0x0.000.000.020.0x0.01N/AN/A
Liabilities-to-EquityN/A0.63+0.5x0.190.140.25-1.4x0.17N/AN/A
Asset Turnover0.11+0.1x0.09+0.1x0.020.030.060.04N/AN/A
FCF Margin-43.5%-87.9%-776.6%-469.6%N/A-381.2%0.5%-117.2%

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Note: Shareholder equity is negative (-$368K), which causes the debt-to-equity, liabilities-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.25), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Hempacco Co Inc HPCO FY2023 $4.0M -$13.4M N/A $592 —
Charlies Holdings Inc CHUC FY2025 $20.9M $4.5M 21.5% $27.8M —
Healthier Choices Mgmt HCMC FY2025 $3K -$7.0M N/A $26.4M —
VPR Brands LP VPRB FY2025 $3.6M -$1.2M -33.1% $8.2M —
LFTD Partners Inc LIFD FY2025 $36.9M -$24.9M -67.3% $1.6M —
Kaival Brands Innvtns Grp KAVL FY2025 $485K N/A N/A $346K —

Frequently Asked Questions

Hempacco Co Inc (HPCO) reported $4.0M in total revenue for fiscal year 2023. This represents a 2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Hempacco Co Inc (HPCO) revenue grew by 2.0% year-over-year, from $4.0M to $4.0M in fiscal year 2023.

No, Hempacco Co Inc (HPCO) reported a net loss of $13.4M in fiscal year 2023.

Hempacco Co Inc (HPCO) had EBITDA of -$12.8M in fiscal year 2023, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2023, Hempacco Co Inc (HPCO) had $110K in cash and equivalents against $0 in long-term debt.

Hempacco Co Inc (HPCO) had a gross margin of -30.0% in fiscal year 2023, indicating the percentage of revenue retained after direct costs of goods sold.

Hempacco Co Inc (HPCO) recorded an outflow of $6.0M in free cash flow during fiscal year 2023. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Hempacco Co Inc (HPCO) recorded an outflow of $5.8M in operating cash flow during fiscal year 2023, representing cash used by core business activities.

Hempacco Co Inc (HPCO) had $18.0M in total assets as of fiscal year 2023, including both current and long-term assets.

Hempacco Co Inc (HPCO) invested $179K in capital expenditures during fiscal year 2023, funding long-term assets and infrastructure.

Hempacco Co Inc (HPCO) had a current ratio of 0.25 as of fiscal year 2023, which is below 1.0, which may suggest potential liquidity concerns.

Hempacco Co Inc (HPCO) had a return on assets of -74.5% for fiscal year 2023, measuring how efficiently the company uses its assets to generate profit.

Hempacco Co Inc (HPCO) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2023). The market capitalization is $592 as of Nov 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Hempacco Co Inc (HPCO) trades at 0.0x sales, its market capitalization divided by $4.0M revenue, FY2023. The market capitalization is $592 as of Nov 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2023, Hempacco Co Inc (HPCO) held $110K in cash, cash equivalents and investments, and reported an operating cash outflow of $5.8M over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Hempacco Co Inc (HPCO) has negative shareholder equity of -$368K as of fiscal year 2023, so no debt-to-equity or liabilities-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

Hempacco Co Inc (HPCO) has an Altman Z-Score of -4.67, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Hempacco Co Inc (HPCO) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Hempacco Co Inc (HPCO) reported a net loss of $13.4M while operations used $5.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Hempacco Co Inc (HPCO) reported an operating loss of $13.2M against $270K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Back to top